Cangene Corporation Acquires U.S. Commercialization Rights for ...
20 Oct 2009 ... TORONTO and WINNIPEG, Oct. 19 /CNW/ - Cangene Corporation today announces that it has signed an agreement with its majority shareholder, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=159674...
|
Cangene Corporation 08-Feb-01 - DETAIL
18 Jun 2009 ... GMP for Finished Products/Biologics/Establishment Licensing.
http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2...
|
BioSpace - Cangene Corporation News, Search Jobs, Events
20 Oct 2009 ... Cangene Corporation 104 Chancellor Matheson Road Winnipeg Manitoba R3T 5Y3 Canada Phone: 204-275-4200 Fax: ...
http://www.biospace.com/company_profile.aspx?CompanyId=4200...
|
Cangene Corporation 22-Sep-00 - DETAIL
18 Jun 2009 ... Good Manufacturing Practices for Blood and Blood Products.
http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2...
|
Cangene Corporation Acquires Twinstrand Therapeutics - News ...
8 Jul 2009 ... TORONTO and WINNIPEG, July 7 /CNW/ - Cangene Corporation today announces that it has acquired all issued and outstanding shares of privately ...
http://www.biospace.com/news_story.aspx?NewsEntityId=149213...
|
m51(03)q '+*.m -—-
Page 2 – Cangene Corporation. 3. Failure to establish and~ol-low sampling a~d testing plans in written procedures to include the method of sampling and the
...
http://www.fda.gov/downloads/ICECI/EnforcementActions/Warnin...
|
Cangene Corporation Opts to Exit European Market with WinRho(R ...
31 Jul 2009 ... TORONTO and WINNIPEG, July 30 /CNW/ - Cangene Corporation today announces that it has withdrawn its Marketing Authorization Applications ...
http://www.biospace.com/news_story.aspx?NewsEntityId=151836...
|
Label - Vaccinia Immune Globulin Intravenous (Human) (VIGIV ...
26 Apr 2005 ... physician or other health care provider to Cangene Corporation at 1-877-CANGENE. (226-4363). An aseptic meningitis syndrome (AMS) has been ...
http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBlo...
|
Cangene Corporation's Human Growth Hormone Drug Submission Is ...
CONTACT: about Cangene Corporation, please contact Jean Compton, Manager, Investor Relations, (905) 405-2900, or by email at jcompton@cangene.com ...
http://www.biospace.com/news_story.aspx?NewsEntityId=24404...
|
NIH Research Portfolio Online Reporting Tool (RePORT)
1 Sep 2009 ... Detail for: CANGENE CORPORATION. Select Year: 2005 | Historic Data. Dollars Awarded by Funding Mechanism ...
http://report.nih.gov/award/trends/FindOrg_Detail.cfm?OrgID=...
|
